JNJ – Johnson & Johnson
Johnson & JohnsonJNJ
$262.37Name : Johnson & Johnson
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $632,285,036,544.00
EPSttm : 8.62
Johnson & Johnson
$262.37
0.78%$2.02
JNJ — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
1.06
Margin Of Safety %
-4
Put/Call OI Ratio
0.7
EPS Next Q Diff
0.13
EPS Last/This Y
-0.08
EPS This/Next Y
1.26
Price
262.42
Target Price
277.81
Analyst Recom
1.81
Performance Q
15.75
Upside
-27.7%
Beta
0.23
Ticker: JNJ
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-20 | JNJ | 248.83 | 0.68 | 0.41 | 337166 |
| 2026-07-21 | JNJ | 251 | 0.67 | 0.44 | 349233 |
| 2026-07-22 | JNJ | 255.64 | 0.66 | 0.87 | 354709 |
| 2026-07-23 | JNJ | 259.3 | 0.67 | 0.18 | 360397 |
| 2026-07-24 | JNJ | 263.39 | 0.68 | 0.21 | 379736 |
| 2026-07-27 | JNJ | 265.98 | 0.73 | 0.99 | 352881 |
| 2026-07-28 | JNJ | 266.68 | 0.72 | 0.92 | 361492 |
| 2026-07-29 | JNJ | 265.63 | 0.74 | 0.20 | 374423 |
| 2026-07-30 | JNJ | 255.88 | 0.71 | 1.22 | 390061 |
| 2026-07-31 | JNJ | 256.44 | 0.73 | 0.25 | 397632 |
| 2026-08-03 | JNJ | 254.45 | 0.74 | 0.61 | 370593 |
| 2026-08-04 | JNJ | 254.95 | 0.74 | 0.26 | 375264 |
| 2026-08-05 | JNJ | 257.57 | 0.71 | 1.08 | 390038 |
| 2026-08-06 | JNJ | 257.02 | 0.73 | 0.37 | 397784 |
| 2026-08-07 | JNJ | 259.23 | 0.72 | 0.35 | 402979 |
| 2026-08-10 | JNJ | 261.85 | 0.71 | 0.64 | 389342 |
| 2026-08-11 | JNJ | 259.76 | 0.70 | 0.76 | 394133 |
| 2026-08-12 | JNJ | 260.84 | 0.71 | 0.96 | 400556 |
| 2026-08-13 | JNJ | 262.12 | 0.71 | 1.01 | 406214 |
| 2026-08-14 | JNJ | 260.38 | 0.72 | 0.68 | 409503 |
| 2026-08-17 | JNJ | 262.41 | 0.70 | 0.54 | 397667 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-20 | JNJ | 248.85 | 8.7 | 5113.4 | 11.64 |
| 2026-07-21 | JNJ | 250.74 | 8.9 | 5841.0 | 11.66 |
| 2026-07-22 | JNJ | 255.68 | 8.9 | 6215.9 | 11.66 |
| 2026-07-23 | JNJ | 259.45 | 8.9 | 6058.1 | 11.66 |
| 2026-07-24 | JNJ | 263.45 | 8.9 | 6094.4 | 11.67 |
| 2026-07-27 | JNJ | 265.93 | 8.9 | 5671.4 | 11.67 |
| 2026-07-28 | JNJ | 266.65 | 8.9 | 5460.6 | 11.68 |
| 2026-07-29 | JNJ | 265.71 | 8.9 | 5226.9 | 11.68 |
| 2026-07-30 | JNJ | 255.86 | 8.9 | 4242.1 | 11.68 |
| 2026-07-31 | JNJ | 256.53 | 8.9 | 5426.2 | 11.68 |
| 2026-08-03 | JNJ | 254.45 | 8.9 | 5118.8 | 11.68 |
| 2026-08-04 | JNJ | 254.45 | 8.9 | 5118.8 | 11.68 |
| 2026-08-05 | JNJ | 257.62 | 6.3 | 5660.8 | 11.62 |
| 2026-08-06 | JNJ | 257.17 | 6.3 | 5289.8 | 11.62 |
| 2026-08-07 | JNJ | 259.23 | 6.2 | 5562.2 | 11.62 |
| 2026-08-13 | JNJ | 262.15 | -13.4 | 3588.3 | 11.05 |
| 2026-08-14 | JNJ | 260.38 | -13.4 | 3263.9 | 11.05 |
| 2026-08-17 | JNJ | 262.42 | -13.4 | 3673.7 | 11.05 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-20 | JNJ | -9.41 | 0.32 | 1.11 |
| 2026-07-21 | JNJ | -9.41 | 0.32 | 1.11 |
| 2026-07-22 | JNJ | -9.96 | 0.32 | 1.11 |
| 2026-07-23 | JNJ | -9.96 | 0.32 | 1.11 |
| 2026-07-24 | JNJ | -9.96 | 0.32 | 1.11 |
| 2026-07-27 | JNJ | -10.64 | 0.43 | 1.14 |
| 2026-07-28 | JNJ | -10.64 | 0.43 | 1.14 |
| 2026-07-29 | JNJ | -8.01 | 0.43 | 1.14 |
| 2026-07-30 | JNJ | -8.01 | 0.43 | 1.14 |
| 2026-07-31 | JNJ | -8.01 | 0.43 | 1.14 |
| 2026-08-03 | JNJ | -8.01 | 0.45 | 1.14 |
| 2026-08-04 | JNJ | -8.01 | 0.45 | 1.14 |
| 2026-08-05 | JNJ | -8.01 | 0.45 | 1.14 |
| 2026-08-06 | JNJ | -8.01 | 0.45 | 1.14 |
| 2026-08-10 | JNJ | -9.72 | 0.27 | 1.14 |
| 2026-08-11 | JNJ | -9.72 | 0.27 | 1.14 |
| 2026-08-12 | JNJ | -8.54 | 0.27 | 1.06 |
| 2026-08-13 | JNJ | -8.54 | 0.27 | 1.06 |
| 2026-08-14 | JNJ | -8.54 | 0.27 | 1.06 |
| 2026-08-17 | JNJ | -11.30 | -0.21 | 1.06 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.9
Avg. EPS Est. Current Quarter
2.42
Avg. EPS Est. Next Quarter
3.02
Insider Transactions
-11.3
Institutional Transactions
-0.21
Beta
0.23
Average Sales Estimate Current Quarter
25192
Average Sales Estimate Next Quarter
26557
Fair Value
252.89
Quality Score
95
Growth Score
82
Sentiment Score
88
Actual DrawDown %
4.5
Max Drawdown 5-Year %
-18.4
Target Price
277.81
P/E
30.42
Forward P/E
20.59
PEG
2.12
P/S
6.46
P/B
7.44
P/Free Cash Flow
28.43
EPS
8.63
Average EPS Est. Cur. Y
11.05
EPS Next Y. (Est.)
12.31
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
21.48
Relative Volume
0.68
Return on Equity vs Sector %
-1.6
Return on Equity vs Industry %
-11.2
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.53
EBIT Estimation
3673.7
◆
JNJ
Healthcare
$262.42
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
57.8
Range 1M
55.5%
Sup Dist
1.3%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
7.4%
EPS NY
10%
52W%
87.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+1.7% upside
Upside
+1.7%
Quality
95
MoS
-4%
JNJ — P/E HistoricalDrug Manufacturers - General
Johnson & JohnsonSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 138200
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
JNJ
Latest News
—
Caricamento notizie per JNJ…
stock quote shares JNJ – Johnson & Johnson Stock Price stock today
news today JNJ – Johnson & Johnson stock forecast ,stock prediction 2023 2024 2025
marketwatch JNJ – Johnson & Johnson yahoo finance google finance
stock history JNJ – Johnson & Johnson invest stock market
stock prices JNJ premarket after hours
ticker JNJ fair value insiders trading